Form 4: USANA Health Sciences Director Winssinger Exercises Stock Options

Sentiment:

SEC Form 4 Filing


Director Frederic J Winssinger exercised stock options in USANA Health Sciences, acquiring 674 shares of common stock on August 2, 2024.

Summary

  • On August 2, 2024, Frederic J Winssinger, a director of USANA Health Sciences Inc, exercised options to acquire 674 shares of common stock.
  • The transaction was executed under Transaction Code 'M', indicating the exercise of a derivative security.
  • Following the transaction, Winssinger directly owns 3,848 shares of USANA common stock.
  • Winssinger also holds 2,023 Restricted Stock Units.
  • The restricted stock units vest in four equal installments on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

  • The transaction has a minor impact on shareholders as it involves the issuance of new shares upon option exercise, potentially diluting existing ownership slightly.

Key Dates

DateDescription
08/02/2024Date of transaction: Director Winssinger exercised stock options and 25% of Restricted Stock Units vest.
11/02/202425% of Restricted Stock Units vest.
02/02/202525% of Restricted Stock Units vest.
05/02/202525% of Restricted Stock Units vest.
08/05/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.